Chemours Co (CC)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Net sales | 1,615 | 1,368 | 1,501 | |
Cost of goods sold | 1,337 | 1,132 | 1,215 | |
Gross profit | 278 | 236 | 286 | |
Equity in earnings of affiliates | 9 | 8 | 11 | |
Interest expense, net | 67 | 66 | 69 | |
Goodwill impairment charge (note 11) | - | - | 56 | |
Selling, general, and administrative expense | 437 | 123 | 135 | |
Research and development expense | 28 | 27 | 29 | |
Restructuring, asset-related, and other charges | 18 | 33 | 45 | |
Total other operating expenses | 483 | 183 | 265 | |
Other income (expense), net | 2 | 5 | 7 | |
(loss) income before income taxes | -261 | - | -30 | |
Provision for income taxes | 119 | 4 | -3 | |
Net (loss) income | -380 | -4 | -27 | |
Less net income attributable to non-controlling interests | 1 | - | - | |
Net income attributable to chemours | -381 | -4 | -27 | |
Earnings per share basic | -2.54 | -0.03 | -0.18 | |
Earnings per share diluted | -2.54 | -0.03 | -0.18 | |
Weighted average number of diluted shares outstanding | 150,238,691 | 149,918,386 | 149,697,616 | |
Weighted average number of shares outstanding basic | 150,238,691 | 149,918,386 | 149,697,616 |